EHD1 and non-small cell lung carcinoma: In non-small cell lung cancer (NSCLC), IL-1β-induced EH domain-containing protein 1 (EHD1), potentiating EGFR-TKI resistance and epithelial-to-mesenchymal transition (EMT) [70].